OSL · MEDI.OL
Medistim ASA
NOK 307.00NOK 0.00 (0.0%)
Medistim ASA’s quoted price sits in the upper half of its reported 52-week range, 2.85% below the high.
Loading market information…
OSL · NANOV.OL · NOK
Stock price, earnings
Quote as of Jul 5, 2023, 02:25 PM UTC. Cached market data; not a live quote.
One-year closing-price history · NOK. Historical prices are not a forecast.
Nordic Nanovector ASA’s quoted price sits in the lower half of its reported 52-week range, 42.19% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Nordic Nanovector ASA’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Nordic Nanovector ASA, an Oslo, Norway-based biopharmaceutical firm, is dedicated to conceiving and commercializing treatments for hematological (blood) cancers. Its most advanced therapeutic, Betalutin—a CD37-targeting antibody-radionuclide conjugate—is currently undergoing Phase 2b clinical trials for individuals afflicted with non-Hodgkin lymphoma. The company's preclinical portfolio also features Alpha37, an anti-CD37 alpha-particle emitting radioimmunoconjugate being investigated for chronic lymphatic leukemia. Nordic Nanovector has forged collaboration agreements with several partners, such as the Paul Scherrer Institute, ArevaMed, LegoChem Bio, and Heidelberg Pharma. Additionally, it maintains a research partnership with the University of Pennsylvania to develop a CD37-targeting CAR-T cell strategy aimed at B-cell malignancies. Incorporated in 2009, the enterprise was formerly known as Nordic Nanovector AS before adopting its current name in 2014.
Latest available per-share figures in NOK. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 09:36 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| May 26, 2020 |
| -NOK 1.39+25.27% vs estimate |
| NOK 0.00 |
KEEP COMPARING
NOK 307.00NOK 0.00 (0.0%)
Medistim ASA’s quoted price sits in the upper half of its reported 52-week range, 2.85% below the high.
NOK 10.52-NOK 0.02 (-0.19%)
Circio Holding ASA’s quoted price sits in the upper half of its reported 52-week range, 33.25% below the high.
NOK 25.80NOK 0.00 (0.0%)
Nordhealth AS’s quoted price sits in the lower half of its reported 52-week range, 32.81% below the high.
NOK 4.15-NOK 0.07 (-1.54%)
Thor Medical ASA’s quoted price sits in the lower half of its reported 52-week range, 41.71% below the high.
NOK 0.59NOK 0.00 (0.0%)
Targovax ASA’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
NOK 0.23NOK 0.00 (0.0%)
REC Silicon ASA’s quoted price sits in the lower half of its reported 52-week range, 91.15% below the high.
NOK 2.05NOK 0.00 (0.0%)
Ultimovacs ASA’s quoted price sits in the lower half of its reported 52-week range, 85.04% below the high.
NOK 1.17NOK 0.00 (0.0%)
BerGenBio ASA’s quoted price sits in the lower half of its reported 52-week range, 92.54% below the high.
